Lightning Medical Research (LMR) is focused on rapidly accelerating progress in scientific research of selected progressive diseases. LMR implements this goal by establishing a direct, real-time relationship between patients and scientific researchers, while fully incorporating doctors into this triad.
The traditional model of disease-related data collection tends to put doctors between patients and researchers, restricting data collection to “doctor sanitized” channels. These are significantly constrained by the limited time doctors can spent with each patient. Scientific researchers are then left to “guess” which hypotheses to test in new controlled studies, aimed at finding a cure or developing new symptom treatments.
LMR connects patients, researchers, doctors, and care-givers directly in real time and removes all incentives to any constituents for failing to act as a global community in the collective effort to eradicate disease.
Scientific researchers can obtain real-time data from an ever-expanding global patient database through LMR, which is perpetually analyzed mathematically to identify innovative and often unexpected lines of new investigative research.
LMR constantly disseminates detailed, relevant information to researchers, doctors, patients, and care-givers, to facilitate accelerated research.
LMR also provides a researcher-to-researcher exchange platform; guidance to doctors for patient visit data collection; as well as current explanations (in non-medical, plain language) to patients on the progress of research into the disease.
LMR is not controlled, funded by, or obligated to any educational institution, commercial or for-profit company, government or non-profit organization, entity, or group of persons.
LMR is dedicated to the confidential treatment of all patient-supplied data and does not seek to derive any profit therefrom. When data reported by patients is supplied to a scientific researcher by LMR, patients are only identified by a number that changes in each and every transfer of information.
LMR therefore merely acts as an impartial “trustee” for the global patient community, united by the fight with that progressive disease.
LMR has selected Parkinson’s Disease as its first of many projects. The global patient base is estimated to be 6+ million people. LMR’s initial goal is to directly obtain targeted and specific data, in an on-going conversation with 100,000 Parkinson’s patients worldwide.
If you have any relationship with Parkinson’s Disease, please REGISTER now to start contributing your knowledge and experience to the fight to eradicate this disease.
In addition, please forward this link to anyone you know who has Parkinson’s Disease.